Search research articles
Contact Us
Filters
Showing results (171-180 of 185) with videos related to
Page
of 19
Sort By:
Thorax
|
June 15, 2016
What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis
H R Stagg, R J Harris, H-A Hatherell, et al.
AJNR. American Journal of Neuroradiology
|
October 19, 2013
Pretreatment ADC histogram analysis is a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma
B M Ellingson, S Sahebjam, H J Kim, et al.
Biochemistry
|
October 3, 1989
Purification of recombinant human tissue factor
L R Paborsky, K M Tate, R J Harris, et al.
Leukemia
|
August 28, 2009
Nilotinib concentration in cell lines and primary CD34(+) chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters
A Davies, N E Jordanides, A Giannoudis, et al.
HIV Medicine
|
April 30, 2019
HIV care cost in England: a cross-sectional analysis of antiretroviral treatment and the impact of generic introduction
K J Ong, A J van Hoek, R J Harris, et al.
HIV Medicine
|
March 5, 2011
Increased detection of the HIV-1 reverse transcriptase M184V mutation using mutation-specific minority assays in a UK surveillance study suggests evidence of unrecognized transmitted drug resistance
A J Buckton, D Prabhu, C Motamed, et al.
AJNR. American Journal of Neuroradiology
|
September 22, 2012
Probabilistic radiographic atlas of glioblastoma phenotypes
B M Ellingson, A Lai, R J Harris, et al.
HIV Medicine
|
August 9, 2011
The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis
M Murray, R S Hogg, V D Lima, et al.
Leukemia
|
January 22, 2010
Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia
J M Allan, N J Sunter, J R Bailey, et al.
Journal of Medicinal Chemistry
|
November 8, 1996
N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP potassium channel openers. Modifications on the western region
C J Ohnmacht, K Russell, J R Empfield, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 185) with videos related to
Sort By:
Page
of 19
Thorax
|
June 15, 2016
What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis
H R Stagg, R J Harris, H-A Hatherell, et al.
AJNR. American Journal of Neuroradiology
|
October 19, 2013
Pretreatment ADC histogram analysis is a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma
B M Ellingson, S Sahebjam, H J Kim, et al.
Biochemistry
|
October 3, 1989
Purification of recombinant human tissue factor
L R Paborsky, K M Tate, R J Harris, et al.
Leukemia
|
August 28, 2009
Nilotinib concentration in cell lines and primary CD34(+) chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters
A Davies, N E Jordanides, A Giannoudis, et al.
HIV Medicine
|
April 30, 2019
HIV care cost in England: a cross-sectional analysis of antiretroviral treatment and the impact of generic introduction
K J Ong, A J van Hoek, R J Harris, et al.
HIV Medicine
|
March 5, 2011
Increased detection of the HIV-1 reverse transcriptase M184V mutation using mutation-specific minority assays in a UK surveillance study suggests evidence of unrecognized transmitted drug resistance
A J Buckton, D Prabhu, C Motamed, et al.
AJNR. American Journal of Neuroradiology
|
September 22, 2012
Probabilistic radiographic atlas of glioblastoma phenotypes
B M Ellingson, A Lai, R J Harris, et al.
HIV Medicine
|
August 9, 2011
The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis
M Murray, R S Hogg, V D Lima, et al.
Leukemia
|
January 22, 2010
Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia
J M Allan, N J Sunter, J R Bailey, et al.
Journal of Medicinal Chemistry
|
November 8, 1996
N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP potassium channel openers. Modifications on the western region
C J Ohnmacht, K Russell, J R Empfield, et al.
Page
of 19